Santiesteban GI, Marrero PCV, Hechavarría TS, Sosa PO

Language: Spanish
References: 18
Page: 971-977
PDF size: 309.94 Kb.

ABSTRACT

A descriptive and cross sectional study was carried out in 87 patients diagnosed with solid liver mass, who were attended in the hospital of Farafenni, Gambia, from January to December 2008, in order to characterize them from clinical, epidemiological and ultrasonic points of view. Sociodemographic and clinical variates were analyzed. Inclusion and exclusion criteria were considered. Also, the percentage as summary measure was used. Male sex, age group of 45-59 years, viral hepatitis B as medical history, and abdominal pain as the most frequent clinical manifestation and multiple nodes and diffuse infiltration as ultrasonic findings prevailed in the series.

REFERENCES

1. Stewart BW, Kleihues P. World cancer report. Lyon: IARCPress; 2003.

2. El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008;134(6):1752-63.

3. Thomas MB, Zhu AX. Hepatocellular carcinoma: the need for progress. J Clin Oncol. 2005;23(13):2892-9.

4. Arguello Pedro T, Rosario A, Escovar J, Muñoz A, Gaitan J, Rey M, et al. Hepatocarcinoma: patología maligna de mal pronóstico. Rev Col Gastroenterol. 2003;18(3):33-7.

5. Steel JL, Eton DT, Cella D, Olek MC, Carr BI. Clinically meaningful changes in health-related quality of life in patients diagnosed with hepatobiliary carcinoma. Ann Oncol. 2006;17(2):304.

6. Furukawa H, Shimamura T, Suzuki T, Taniguchi M, Yamashita K, Kamiyama T, et al. Living- donor liver transplantation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2006;13(5):393.

7. Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF, et al. Treatment of unreceptable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol. 2005;16(2):205-13.

8. Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, et al. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV Cirrhosis. Gastroenterology. 2006;131(6):1758-67.

9. Parikh S, Hyman D. Hepatocellular Cancer: A guide for the internist. Am J Med. 2007;120:194-202.

10. Parkin DM, Ferlay J, Hamdi-Chérif M, Sitas F, Thomas JO, Wabinga H, et al. Cancer in Africa: epidemiology and prevention. IARC Scientific Publications. Lyon: IARCPress; 2003. p.299-314.

11. Kew MC, Marcus R, Geddes EW. Some characteristic of Mozambican Shangaans with primary hepatocellular cancer. S Afr Med J. 1977;51:306-9.

12. Cuadrado A, Crespo J, Cabriada J, Pons-Romero F. Fever, pain in right hypochondrium and liver mass with central calcification. Rev Esp Enferm Dig (Madrid). 2004;96(5):331-43.

13. Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al. Harrison's Principles of Internal Medicine. Vol 1. 17 ed. Madrid: McGraw-Hill; 2008. p. 580-85.

14. Smok SG. Carcinoma primitivo del hígado. Estudio de 85 casos de necropsia. Rev Méd Chile. 1986;114(7):653-8.

15. Velderrain Zazueta P. Estudio sonográfico del abdomen superior San José del Cabo B.C.S. 2005.

16. Thorgeirsson SS, Lee JS, Grisham JW. Molecular prognostication of liver cancer: end of the beginning. J Hepatol. 2006;44(4):798.

17. Xiol X. Estudio del nódulo hepático aislado. GH Continuada. 2003;2(4):151-5.

18. Martín Algíbez A, Castellano Tortajada G. Seguimiento ecográfico de los pacientes con hepatopatía crónica. [citado 15 Mar 2011]. Disponible en: http://www.ecodigest.net/revista/numeros/num_1/num_1_3.pdf